Follow
Onxeo S.A.
Nasdaq First North GM (Denmark)
Onxeo SA is a biotechnology company that is engaged in developing oncology drugs based on tumor DNA targeting. The company focuses on developing disruptive compounds from preclinical research. It produces and develops orphan oncology products under the brand names Livatag, Validive, Beleodaq, platON, and AsiDNA.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
ONXEO
FR0010095596
Nasdaq First North GM
Denmark (DK)
Details of share in Onxeo S.A. with ticker ONXEO
Status
Active
Order book id
Amount of instruments
78 317 810
Par value
Currency
DKK
Type
Price
Pre-money
Time
Files
Listing
14 Dec 2020
Direct listing of Onxeo S.A. on Nasdaq First North GM
Type
Ticker
ISIN
Market
SHARE
ALONX
FR0010095596
Details of share in Onxeo S.A. with ticker ALONX
Status
Delisted
Order book id
Amount of instruments
78 317 810
Par value
Currency
EUR
Type
Price
Pre-money
Time
Files
Market move
15 Dec 2020
Listing of Onxeo S.A. on Euronext Growth Paris
Type
Price
Pre-money
Time
Files
Delisting
30 Mar 2021
Delisting of Onxeo S.A. from Euronext Growth Paris
Type
Ticker
ISIN
Market
SHARE
ONXEO
FR0010095596
Nasdaq First North GM
Denmark (DK)
Details of share in Onxeo S.A. with ticker ONXEO
Status
Active
Order book id
Amount of instruments
78 317 810
Par value
Currency
DKK
Type
Price
Pre-money
Time
Files
Listing
14 Dec 2020
Direct listing of Onxeo S.A. on Nasdaq First North GM
Type
Ticker
ISIN
Market
SHARE
ALONX
FR0010095596
Details of share in Onxeo S.A. with ticker ALONX
Status
Delisted
Order book id
Amount of instruments
78 317 810
Par value
Currency
EUR
Type
Price
Pre-money
Time
Files
Market move
15 Dec 2020
Listing of Onxeo S.A. on Euronext Growth Paris
Type
Price
Pre-money
Time
Files
Delisting
30 Mar 2021
Delisting of Onxeo S.A. from Euronext Growth Paris
Type
Ticker
ISIN
Market
OPTION
ONXDS
FR0014001YS4
Euronext Growth Paris
France (FR)
Details of option in Onxeo S.A. with ticker ONXDS
Status
Archived
Order book id
Amount of instruments
13 052 968
Currency
SEK
Terms
People
Judith Greciet
CEO
Danièle Guyot-Caparros
Chairman of the board
Judith Greciet
Board member
Audrey Legentil-Duméry
Board member
Company Details
Sector
HEALTH CARE
Website

Address
49 Boulevard du Général Martial Valin
Zip code
FR-75015
City/district
Paris
Country
France (FR)
Registration number
410 910 095
LEI code
96950018AS30IUG0V528
First trade date
12 Jul 2005
Registration date
08 Feb 1997
Short name
Onxeo

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More